Mabpharm Limited (the “Company,” Stock Code: 2181) issued a letter dated 10 February 2026 reminding non-registered shareholders of its arrangement for the electronic dissemination of corporate communications. According to the notice, both English and Chinese versions of each future corporate communication are available on the Company’s website and on the HKEXnews website, replacing printed copies.

Non-registered shareholders are encouraged to provide their email addresses to their respective banks, brokers, custodians, or other intermediaries to ensure timely receipt of information. Those wishing to receive printed versions may submit a completed reply form to the Hong Kong branch share registrar. The Company reiterated that maintaining up-to-date communication details is important for receiving ongoing corporate disclosures and announcements in a timely manner.